当前位置: 首页 > 详情页

Association of APOE-ε4 and GAP-43-related presynaptic loss with β-amyloid, tau, neurodegeneration, and cognitive decline

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China [2]Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China [3]Department of Neurology, University of Chinese Academy of Sciences-Shenzhen Hospital, Shenzhen, China [4]Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China [5]Institute of Biomedical Engineering, Peking University Shenzhen Graduate School, Shenzhen, China
出处:
ISSN:

关键词: Alzheimer’s disease Apolipoprotein E Presynaptic loss Growth-associated protein-43 Neurodegeneration Cognition

摘要:
Apolipoprotein E-ε4 (APOE-ε4) carriers had elevated cerebrospinal fluid (CSF) presynaptic protein growth-associated protein-43 (GAP-43), but the underlying mechanism is not fully understood. We investigated how the APOE-ε4 genotype affects the baseline and longitudinal changes in CSF GAP-43 and their associations with β-amyloid positron emission tomography (Aβ PET), CSF phosphorylated tau 181 (p-Tau181), neurodegeneration, and cognitive decline. Compared to APOE-ε4 non-carriers, APOE-ε4 carriers had higher baseline levels and faster rates of increases in Aβ PET, CSF p-Tau181, and CSF GAP-43. Both higher baseline levels and faster rates of increase in CSF GAP-43 were associated with greater baseline Aβ PET and CSF p-Tau181, which fully mediated the APOE-ε4 effect on CSF GAP-43 elevations. Independent of Aβ PET and CSF p-Tau181, APOE-ε4 carriage was associated with exacerbated GAP-43-related longitudinal hippocampal atrophy and cognitive decline, especially in Aβ+ participants (GAP-43 × time × APOE-ε4). These findings suggest that the APOE-ε4 effect on GAP-43-related presynaptic dysfunction is mediated by primary Alzheimer's pathologies and independently correlates to hippocampal atrophy and cognitive decline in the future.Copyright © 2023 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 2 区 医学
小类 | 2 区 神经科学 3 区 老年医学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 老年医学 3 区 神经科学
JCR分区:
出版当年[2021]版:
Q2 GERIATRICS & GERONTOLOGY Q2 NEUROSCIENCES
最新[2023]版:
Q2 GERIATRICS & GERONTOLOGY Q2 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China
通讯作者:
通讯机构: [1]Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China [5]Institute of Biomedical Engineering, Peking University Shenzhen Graduate School, Shenzhen, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院